Corinna Trenker, Jessica Kümpel, Christian Michel, Ehsan Safai Zadeh, Christoph F Dietrich, Nina Timmesfeld, Andreas Neubauer, Andreas Burchert, Christian Görg
OBJECTIVES: Here we asked, whether contrast enhanced ultrasound (CEUS) enables to judge early treatment response in malignant lymphoma as a potential guidance for further treatment. METHODS: From May 2017 to May 2018, 21 patients with histologically confirmed diagnosis of lymphoma were examined by B-mode ultrasound (B-US) and CEUS at fixed early time points after commencing therapy (days [d] 0, 15 and 30 after therapy start) and contrast enhancement patterns in target lymphoma lesions were quantified using Bracco-VUE Box® (DCE-US)...
November 30, 2021: Journal of Ultrasound in Medicine: Official Journal of the American Institute of Ultrasound in Medicine